Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2021-09-22 00:00:00 ET · period of report 2021-09-20 · accession 0001562180-21-006060 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-22 | 2021-09-20+ | SNDX | Metzger Michael A | Pres, COO, Dir | S - Sale+OE | $19.23 | -36.6K | 17.7K | -67% | -$703.0K |
| DM | 2021-09-22 | 2021-09-20+ | SNDX | Metzger Michael A | Pres, COO, Dir | M - OptEx | $7.20 | +36.6K | 18.0K | New | +$263.3K |
| DM | 2021-09-22 | 2021-09-20+ | SNDX | Metzger Michael A | Pres, COO, Dir | M - OptEx | $0.00 | -36.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-20 | S | D | 31,455 | $19.24 | 17,659 | D | — | — | (F2) The sale price ranged from $19.00 to $19.92 |
| 2 | Common | Common Stock | 2021-09-20 | M | A | 31,455 | $7.20 | 49,114 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-22 | S | D | 300 | $19.02 | 17,659 | D | — | — | (F4) The sale prices ranged from $19.00 to $19.06 |
| 4 | Common | Common Stock | 2021-09-21 | M | A | 4,808 | $7.20 | 22,467 | D | — | — | |
| 5 | Common | Common Stock | 2021-09-21 | S | D | 4,808 | $19.16 | 17,659 | D | — | — | (F3) The sale prices ranged from $19.02 to $19.31 |
| 6 | Common | Common Stock | 2021-09-22 | M | A | 300 | $7.20 | 17,959 | D | — | — | |
| 7 | Derivative | Stock Options (Right to buy) | 2021-09-22 | M | D | 300 | $0.00 | 0 | D | $7.20 · — to 2025-06-01 | 300 Common Stock | (F5) This option is fully vested. |
| 8 | Derivative | Stock Options (Right to buy) | 2021-09-20 | M | D | 31,455 | $0.00 | 0 | D | $7.20 · — to 2025-06-01 | 31,455 Common Stock | (F5) This option is fully vested. |
| 9 | Derivative | Stock Options (Right to buy) | 2021-09-21 | M | D | 4,808 | $0.00 | 0 | D | $7.20 · — to 2025-06-01 | 4,808 Common Stock | (F5) This option is fully vested. |